U.S. Gas Utilities Stock News

NYSE:JBTM
NYSE:JBTMMachinery

Does JBT Marel’s (JBTM) Steady Guidance And Buybacks Reveal A New Capital Allocation Playbook?

JBT Marel Corporation recently reported second-quarter 2026 results showing higher sales of US$981 million and net income of US$28 million, reaffirmed full-year 2026 revenue guidance of US$3.99 billion to US$4.07 billion with GAAP diluted EPS of US$4.20 to US$4.70, recognized US$33 million of intangible asset impairments, completed a US$26 million share buyback of 200,000 shares, and previously declared a quarterly cash dividend of US$0.10 per share that was paid on August 31, 2026 to...
NYSE:VVX
NYSE:VVXAerospace & Defense

Can V2X (VVX) Justify Its Valuation As New Defense Contracts And Higher Guidance Land?

V2X (VVX) has drawn fresh investor attention after securing two multi year U.S. defense support contracts worth up to a combined $587 million, along with reporting higher quarterly earnings and raising full year 2026 guidance. See our latest analysis for V2X. These contract wins and higher guidance sit alongside a strong recent run in V2X’s stock, with a 30 day share price return of 12.56% and a year to date gain of 51.93%. The 1 year total shareholder return of 59.47% points to momentum that...
NasdaqGS:NXST
NasdaqGS:NXSTMedia

Is Nexstar Media Group (NXST) Undervalued On Strong Q2 2026 Earnings?

Nexstar Media Group (NXST) drew fresh attention after reporting second quarter 2026 results, with higher sales, net income and earnings per share compared with a year earlier, alongside a recently affirmed quarterly cash dividend. See our latest analysis for Nexstar Media Group. Nexstar Media Group's latest earnings and dividend update arrives after a mixed stretch for the stock. A 1-month share price return of 11.34% contrasts with a share price that is down 7.21% year to date and a 1-year...
NYSE:J
NYSE:JProfessional Services

How Investors May Respond To Jacobs Solutions (J) Revenue Gain, Profit Dip, And LA Metro EV Contract

Jacobs Solutions Inc. has reported past third-quarter 2026 results showing sales of US$4,076.41 million, up from US$3,031.77 million a year earlier, while quarterly net income decreased to US$136.55 million from US$179.61 million, alongside a declared quarterly dividend of US$0.36 per share. At the same time, Jacobs was selected by LA Metro and Clark Construction to design and build advanced zero-emission bus charging infrastructure ahead of the 2028 Olympic and Paralympic Games,...
NYSE:WRB
NYSE:WRBInsurance

W. R. Berkley (WRB) Could Be 5% Overvalued As Leadership Changes Raise Questions

Leadership changes at Berkley Re and what they might mean for W. R. Berkley stock W. R. Berkley (WRB) has reshaped leadership across its reinsurance operations, appointing Daniel R. Westcott as executive vice president and naming Robert R. Coyne, Jr. and Robert C. Hewitt to new roles at Berkley Re. See our latest analysis for W. R. Berkley. At a last close of US$71.60, W. R. Berkley’s share price has eased slightly over the past month, although the 90 day share price return of 7.57% and a 5...
NasdaqGS:LFST
NasdaqGS:LFSTHealthcare

How Investors Are Reacting To LifeStance Health Group (LFST) Profit Return, Guidance Hike, And New Buyback

LifeStance Health Group recently reported its second-quarter 2026 results, posting US$435.35 million in sales and returning to profitability, while also completing a buyback of 13,000,000 shares for US$97.19 million under a previously announced program and launching a new authorization of up to US$100 million in repurchases. Alongside raising both third-quarter and full-year 2026 revenue guidance, management pointed to clinician productivity gains, specialty service growth, and improved...
NYSE:NE
NYSE:NEEnergy Services

What Noble (NE)'s Earnings Miss, Lowered Outlook and Payouts Mean For Shareholders

Noble Corporation plc recently reported second-quarter 2026 results showing revenue of US$719.69 million and a net loss of US$36.68 million, while also completing a share repurchase program totaling 1,048,262 shares for US$29.82 million and affirming a US$0.50 quarterly dividend for payment in September 2026. The shift from profit to loss, combined with slightly reduced full-year 2026 revenue guidance to US$2.8–US$2.9 billion, highlights pressure on Noble’s current operations even as it...
NYSE:LEN
NYSE:LENConsumer Durables

Is Lennar (LEN) Using Premium Valencia Launch to Quietly Redefine Its Volume-Driven Strategy?

Lennar has held the Grand Opening of Sutton and Hollis, two new single-family home collections at Valencia in Santa Clarita Valley, offering six floorplans ranging from 2,663 to 3,555 square feet with pricing starting in the low US$1,000,000s. By adding higher-end homes with resort-style amenities and access to highly rated schools in a sought-after Southern California master-planned community, Lennar is broadening its product mix to appeal to a range of lifestyle-focused buyers. Next, we’ll...
NasdaqGS:ARCB
NasdaqGS:ARCBTransportation

How Investors Are Reacting To ArcBest (ARCB) Profit Swing, Major Buyback Completion And New Digital Platform

In the past quarter, ArcBest Corporation reported second-quarter 2026 results showing sales rising to US$1,184.53 million while swinging from net income of US$25.81 million to a net loss of US$13.82 million, with losses per share replacing prior-year earnings. Alongside these results, ArcBest completed a very large, long-running buyback program totaling 7,802,528 shares for US$507.23 million, while introducing cost-saving organizational changes and its new ArcBestView digital logistics...
NasdaqGM:ALVO
NasdaqGM:ALVOBiotechs

Did FDA’s Positive Reykjavik Plant Outcome Just Shift Alvotech’s (ALVO) Biosimilar Expansion Narrative?

Alvotech announced that the U.S. Food and Drug Administration has closed its May 2026 inspection of the company’s Reykjavik, Iceland manufacturing facility with a Voluntary Action Indicated classification, confirming that the actions taken have addressed the FDA’s observations and allowing the company to continue advancing multiple Biologics License Applications for its biosimilar candidates. This outcome, together with recent resubmissions and acceptance of BLAs for biosimilars to Simponi,...
NYSE:BRK.B
NYSE:BRK.BDiversified Financial

What Is Berkshire Hathaway (BRK.B) Signaling With Its Biggest Buyback Since 2021?

Berkshire Hathaway (NYSE:BRK.B) reported Q2 2026 results that included a clear shift in capital allocation under new CEO Greg Abel. The company executed significant share buybacks in Q2 2026, marking its largest quarterly repurchase since 2021. Berkshire initiated a sizable new equity position in Alphabet and returned to being a net buyer of stocks using part of its large cash balance. This renewed appetite for deploying cash into equities points to a broader theme of capital return and...
NYSE:MPT
NYSE:MPTHealth Care REITs

Should Medical Properties Trust’s US$2.40 Billion Refinancing and Asset Sales Require Action From MPT Investors?

Medical Properties Trust, Inc. has reported past second-quarter 2026 results showing sales of US$236.71 million and revenue of US$259.28 million, with the quarterly net loss narrowing sharply to US$2.6 million and six‑month results swinging to net income of US$30.23 million. Alongside these mixed earnings, the company unveiled a roughly US$2.40 billion secured notes transaction, asset sales expected to raise about US$172 million, and a new US$55.92 million shelf registration, underscoring a...
NasdaqGM:MNKD
NasdaqGM:MNKDBiotechs

Is MannKind (MNKD) Undervalued After Positive INFLO 1 Data For Its IPF Pipeline?

MannKind (MNKD) recently drew investor attention after reporting positive topline Phase 1b INFLO-1 data for its inhaled nintedanib therapy in idiopathic pulmonary fibrosis patients, highlighting safety, tolerability, and effective deep lung delivery. See our latest analysis for MannKind. The INFLO-1 update has come alongside a sharp move in MannKind’s stock, with a 1-day share price return of 5.66% and a 90-day share price return of 25.30%. However, the year-to-date share price return is down...
NYSE:SLB
NYSE:SLBEnergy Services

SLB (SLB) Stock May Look Below Fair Value On Cash Flow But About Right On Earnings

SLB has more than doubled investors' money over the past five years, yet its current share price near US$50.53 still sits well below an intrinsic value estimate from a Discounted Cash Flow (DCF) model that points to a 43.6% discount. With that backdrop, recent headlines around offshore stimulation work with Equinor and AI driven drilling operations with ADNOC are being weighed against a reported profit decline linked to disruptions in the Middle East. SLB has returned 103.0% over 5 years,...
NasdaqGS:CECO
NasdaqGS:CECOMachinery

What CECO Environmental (CECO)'s Strong Revenue Growth and Net Loss Widening Means For Shareholders

CECO Environmental Corp. has reported past second-quarter 2026 results, with sales rising to US$284.96 million from US$185.39 million a year earlier, but moving from net income of US$9.51 million to a net loss of US$34.77 million, or basic loss per share of US$0.80 from earnings per share of US$0.27. Despite reporting a loss for both the quarter and first half, CECO Environmental lifted full-year revenue guidance above analyst expectations while delivering revenue ahead of consensus...
NasdaqGS:VNOM
NasdaqGS:VNOMOil and Gas

3 Energy Stocks Getting Attention As Strait Of Hormuz Risks Lift Oil Prices

Oil prices are in the headlines again as Iran links reopening the Strait of Hormuz to US concessions, and that ripples straight through inflation expectations, interest rate worries, and energy sector stocks. For investors, these kinds of shocks can reshuffle winners and laggards quickly. This article walks through how this backdrop connects to three large cap energy stocks in our screener that appear positively exposed to the latest Hormuz story. The stocks in the article below are just a...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Intel (INTC) Unveils $15 Billion Stock Offering As AI Buildout Accelerates

Intel (NasdaqGS: INTC) announces a US$15b underwritten public stock offering to fund AI and chip manufacturing expansion. The company plans to use the capital for its contract chip manufacturing business and AI related technologies, while maintaining financial flexibility. The offering size and AI focus mark a material development for Intel's long term strategy and its position in global semiconductor manufacturing. For readers looking to compare this move with other companies building out...
NYSE:MSA
NYSE:MSACommercial Services

Did Strong Q2 Results and Autronica Deal Just Shift MSA Safety's (MSA) Investment Narrative?

In late July and early August 2026, MSA Safety reported higher second-quarter sales and earnings, confirmed its full-year 2026 outlook for low-double-digit revenue growth, completed the Autronica Fire & Security acquisition, continued share repurchases, and declared third-quarter common and preferred dividends of US$0.54 and US$0.5625 per share respectively. Together, these updates highlight MSA’s focus on earnings growth, disciplined use of leverage for acquisitions, and ongoing cash...
NYSE:AFL
NYSE:AFLInsurance

Aflac (AFL) Just Gave Investors Something To Think About

Aflac earnings, dividend and buyback update Aflac (AFL) is back in focus after reporting second quarter 2026 results, declaring a third quarter dividend of $0.61 per share, and updating investors on progress under its long running share repurchase program. See our latest analysis for Aflac. Aflac's recent earnings, dividend affirmation and ongoing buybacks come after a period where the share price has risen 13.04% year to date and the 1 year total shareholder return is 22.17%, building on a 5...
NasdaqGM:VITL
NasdaqGM:VITLFood

US Consumer Staples Stocks That Could Hold Up Longer Under High Rates

With the U.S. unemployment rate sitting at 4.1% and inflation still above the Fed’s 2% target, investors are watching how longer lasting tight monetary policy could ripple through everything from paychecks to pantry staples. That mix can reshape which consumer stocks feel pressure and which hold up. This article breaks down three large consumer staples stocks exposed to these trends and why they may deserve a closer look now. The three stocks highlighted below are just a sample. The full...
NYSE:XOM
NYSE:XOMOil and Gas

ExxonMobil (XOM) Stock Still Looks Below Fair Value Today

ExxonMobil Holdings has returned 223.9% over the past five years, and current valuation checks suggest the stock still trades at a discount to its intrinsic value estimate and earnings based multiples. Over five years, a 223.9% total return signals that long term holders have already captured substantial gains and may now be weighing how much value is left in the current share price. Stronger recent cash generation and large scale shareholder returns can support the intrinsic value case,...
NasdaqGS:AMAT
NasdaqGS:AMATSemiconductor

How Investors May Respond To Applied Materials (AMAT) AI Tool Demand And Record FY25 Results

In recent days, Applied Materials has been in focus as a key semiconductor equipment bellwether ahead of an upcoming earnings report, with analysts highlighting its role in AI-related wafer fabrication demand and its record fiscal 2025 results, including higher dividends after 16 consecutive years of increases. At the same time, major planned AI chip investments such as Tesla and SpaceX’s multibillion‑dollar Terafab complex have reinforced Applied Materials’ position at the center of the AI...
NYSE:CRBG
NYSE:CRBGDiversified Financial

Corebridge Financial (CRBG) Is Up 7.6% After Q2 Profit, Capital Returns And Annuity Expansion

In August 2026, Corebridge Financial, Inc. declared a US$0.25 per-share common dividend, completed a US$5.96 billion share repurchase program after buying back an additional US$300 million in stock, and reported second-quarter 2026 results showing revenue of US$3,914 million and net income of US$2 million compared with a net loss a year earlier. Alongside the earnings improvement, Corebridge expanded its Power Series of Index Annuities with the Protected Growth Benefit and preset allocation...
NasdaqCM:PLSE
NasdaqCM:PLSEMedical Equipment

Pulse Biosciences (PLSE) After NANOPULSE AF Progress As Valuation Questions Build

Pulse Biosciences (PLSE) is back in focus after reporting a wider quarterly net loss and filing a US$75 million at the market equity offering, as its NANOPULSE-AF Study passes the enrollment midpoint. See our latest analysis for Pulse Biosciences. The recent NANOPULSE-AF Study milestone and the US$75 million at the market offering come after a powerful run in Pulse Biosciences' stock, with a 30 day share price return of 61.32% and year to date share price return of 216.73%. The 3 year total...